<DOC>
	<DOCNO>NCT01876706</DOCNO>
	<brief_summary>The purpose study evaluate procedure tolerability surgical recovery follow UroLift® system procedure conduct local anesthesia subject symptomatic benign hyperplasia ( BPH ) . Primary effectiveness achieve look Quality Recovery Visual Analog Scale ( QoR VAS ) one month follow-up visit .</brief_summary>
	<brief_title>UroLift System TOlerability ReCovery When Administering Local Anesthesia</brief_title>
	<detailed_description>The randomized portion study prospective , multicenter , non-blinded , single arm trial evaluate procedure tolerability surgical recovery follow UroLift® system procedure conduct local anesthesia . All subject undergo UroLift system treatment follow 5 year receive investigational device .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Males age 50 year old diagnose symptomatic benign prostatic hyperplasia ( BPH ) Size , volume , length prostate</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>UroLift System</keyword>
</DOC>